Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)
Iram Zafar(University of Alabama at Birmingham), Charles L. Edelstein(University of Colorado Denver)
Cited by 86
Related Papers
Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice
|The Journal of Immunology|2003|277
NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
|Journal of Pharmacology and Experimental Therapeutics|2013|135
mTOR promotes the formation and growth of tertiary lymphoid tissues in the kidney
|Frontiers in Immunology|2025|0